Development and evaluation of pH-responsive single-walled carbon nanotube-doxorubicin complexes in cancer cells

References

• FoldvariMBagonluriMCarbon nanotubes as functional excipients for nanomedicines. II Drug delivery and biocompatibility issuesNanomedicine20084317318218550451
   PubMed Web of Science ®Google Scholar
• LiuZTabakmanSWelsherKDaiHCarbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug deliveryNano Res2009228512020174481
   PubMed Web of Science ®Google Scholar
• KamNWDaiHCarbon nanotubes as intracellular protein transporters: generality and biological functionalityJ Am Chem Soc2005127166021602615839702
   PubMed Web of Science ®Google Scholar
• PantarottoDSinghRMcCarthyDFunctionalized carbon nanotubes for plasmid DNA gene deliveryAngew Chem Int Ed2004433952425246
   PubMed Web of Science ®Google Scholar
• LiuYWuDCZhangWDPolyethylenimine-grafted multiwalled carbon nanotbue for secure noncovalent immobilization and efficient delivery of DNAAngew Chem Int Ed2005443047824785
   Web of Science ®Google Scholar
• KamNWLiuZDaiHFunctionalization of carbon nanotbues via cleavable disulfide bonds for efficient intracelluar delivery of siRNA and potent gene silencingJ Am Chem Soc200512736124921249316144388
   PubMed Web of Science ®Google Scholar
• KostarelosKLacerdaLPastorinGCellular uptake of functionalized carbon nanotubes in independent of functional groups and cell typeNat Nanotechnol2007210811318654229
   PubMed Web of Science ®Google Scholar
• LiuZDavisCCaiWHeLCheXDaiHCirculation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopyProc Natl Acad Sci200810551410141518230737
   PubMed Web of Science ®Google Scholar
• ChengJShiralFernandokMonicaKAVecaLReversible accumulation of PEGylated single-walled carbon nanotubes in the mammalian nucleus ACSNano200821020852094
   Web of Science ®Google Scholar
• DharSLiuZThomaleJDaiHLippardSJTargeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing deviceJ Am Chem Soc200813034114671147618661990
   PubMed Web of Science ®Google Scholar
• KostarelosKThe long and short of carbon nanotubes toxicityNat Biotech2008267774776
   PubMed Web of Science ®Google Scholar
• PastorinGWuWWieckwskiSDouble functionalisation of carbon nanotubes for multimodal drug deliveryChem Comm2006111182118416518484
   PubMed Web of Science ®Google Scholar
• LiuZSunXNakayama-RatchfordNDaiHSupramolecular chemistry on water-soluble carbon nanotubes for drug loading and deliveryACS Nano200711505619203129
   PubMed Web of Science ®Google Scholar
• Ali-BoucettaHAl-JamalKTMcCarthyDPratoMBiancoAKostarelosKMultiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeuticsChem Comm2008445946118188467
   PubMed Web of Science ®Google Scholar
• LiuZFanACRakhraKSupermolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapyAngew Chem Int Ed2009484176687672
   PubMed Web of Science ®Google Scholar
• ZhangXMengLLuQFeiZDysonPJTargeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubesBiomaterials200930306041604719643474
   PubMed Web of Science ®Google Scholar
• ChenJChenSZhaoXKuznetsovaLVWongSSOjimaIFunctionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug deliveryJ Am Chem Soc200813049167781678519554734
   PubMed Web of Science ®Google Scholar
• LiuZChenKDavisCDrug delivery with carbon nanotubes for in vivo cancer treatmentCancer Res200868166652666018701489
   PubMed Web of Science ®Google Scholar
• WuWLiRBianXCovalently combining carbon nanotubes with anticancer agent: preparation and antitumor activityACS Nano2009392740275019702292
   PubMed Web of Science ®Google Scholar
• ChaudhuriPSoniSSenguptaSSingle-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanomaNanotechnology20102102510219955607
   PubMed Web of Science ®Google Scholar
• GatenbyRAGilliesRJWhy do cancers have high aerobic glycolysis?Nat Rev Cancer200441189189915516961
   PubMed Web of Science ®Google Scholar
• DenkoNCHypoxia, HIF 1 and glucose metabolism in the solid tumorNat Rev Cancer20088970571319143055
   PubMed Web of Science ®Google Scholar
• LiCXiaJWeiXYanHSiZJuSpH-activated near-infrared fluorescence nanoprobe imaging tumors by sensing the acidic microenvironmentAdv Funct Mater2010201422222230
   Web of Science ®Google Scholar
• EtrychTJelínkováMŘíhováBUlbrichKNew HPMA copolymers containing doxorubicin bound via pH sensitive linkage: synthesis and preliminary in vitro and in vivo biological propertiesJ Controlled Release200173189102
   Web of Science ®Google Scholar
• LeeCCCramerATSzokaFCJrFréchetJMJTumor-targeting, pHresponsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapyBioconjugate Chem2006173496504
   Google Scholar
• YangXGrailerJJPillaSSteeberDGongSTumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapyBioconjugate Chem2010213496504
   PubMed Web of Science ®Google Scholar
• AryalSGrailerJJPillaSSteeberDAGongSDoxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriersJ Mater Chem20091978797884
   Web of Science ®Google Scholar
• PrabaharanMGrailerJJPillaSSteeberDAGongSGold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug deliveryBiomaterials200930306065607519674777
   PubMed Web of Science ®Google Scholar
• ChengJGuYJWangYChengSHWongWTNanotherapeutics in angiogenesis: synthesis and in vivo assessment of drug efficacy and biocompatibility in zebrafish embryosInt J Nanomedicine201162007202121976976
   PubMed Web of Science ®Google Scholar
• ŘíhováBEtrychTŠírováMSynergistic action of doxorubicin bound to the polymeric carrier based on N-(2-hydroxypropyl) methacrylamide copolymers through an amide or hydrazone bondMol Pharmacol20107410271040
   PubMed Web of Science ®Google Scholar
• BodleyALiuLFIsraelMSeshadriRKosekiYGiulianiFCDNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin conjugates with DNACancer Res19894921596959782551497
   PubMed Web of Science ®Google Scholar
• CummingsJSmythJFDNA topoisomerase I and II as targets for rational design of new anticancer drugsAnn Oncol1993475335438395870
   PubMed Web of Science ®Google Scholar
• FornariFARandolphJKYalowichJCRitkeMKGewirtzDAInterference by doxorubicin with DNA unwinding in MCF-7 breast tumor cellsMol Pharmacol19944546496568183243
   PubMed Web of Science ®Google Scholar
• AbdElWahedMGAbdElWaneesSGamel ElMAbdElHaleemSPhysical studies of some hydrazinobenzoic acid complexesJ Mater Sci Technol2005211140144
   Web of Science ®Google Scholar
• JainAKDubeyVMehraNKCarbohydrate-conjugated multiwalled carbon nanotubes: development and characterizationNanomedicine2009543244219341818
   PubMed Web of Science ®Google Scholar
• ŘíhováBEtrychTPecharMDoxorubicin bound to a HPMA copolymer carrier through hydrazone bond is also effective in a cancer cell line with a limited content of lysosomeJ Controlled Release2001741–3225232
   Web of Science ®Google Scholar